Compromised blood-brain barrier permeability: Novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension

Journal of Physiology

Volumn 594, Issue 6, 2016, Pages 1591-1600

  Biancardi, V C ^a   Stern, J E ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; REACTIVE OXYGEN METABOLITE;

ARTICLE; BLOOD BRAIN BARRIER; BLOOD PRESSURE REGULATION; ENCEPHALITIS; EXCITATION; HYPERTENSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ROSTRAL VENTROLATERAL MEDULLA; SIGNAL TRANSDUCTION; SYMPATHOEXCITATORY; ADRENERGIC SYSTEM; ANIMAL; BLOOD; CAPILLARY PERMEABILITY; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; HUMANS; HYPERTENSION; SYMPATHETIC NERVOUS SYSTEM;

EID: 84952342935     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP271584     Document Type: Article

References (93)

1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR & Begley DJ (2010). Structure and function of the blood-brain barrier. Neurobiol Dis 37, 13-25.
2. Abbott NJ, Ronnback L & Hansson E (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7, 41-53.
3. Anderson JW, Smith PM & Ferguson AV (2001). Subfornical organ neurons projecting to paraventricular nucleus: whole-cell properties. Brain Res 921, 78-85.
4. Bains JS & Ferguson AV (1995). Paraventricular nucleus neurons projecting to the spinal cord receive excitatory input from the subfornical organ. Am J Physiol 268, R625-R633.
5. Bains JS, Potyok A & Ferguson AV (1992). Angiotensin II actions in paraventricular nucleus: functional evidence for neurotransmitter role in efferents originating in subfornical organ. Brain Res 599, 223-229.
6. Benicky J, Sanchez-Lemus E, Pavel J & Saavedra JM (2009). Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery. Cell Mol Neurobiol 29, 781-792.
7. Bergamaschi CT, Biancardi VC, Lopes OU & Campos RR (2002). Effects of angiotensin blockade in the rostral ventrolateral medulla on maintenance of hypertension induced by chronic l-NAME treatment. Brain Res 927, 195-199.
8. Biancardi VC, Son SJ, Ahmadi S, Filosa JA & Stern JE (2014). Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier. Hypertension 63, 572-579.
9. Braga VA, Medeiros IA, Ribeiro TP, França-SilvaMS, Botelho-Ono MS & Guimarães DD (2011). Angiotensin-II-induced reactive oxygen species along the SFO-PVN-RVLM pathway: implications in neurogenic hypertension. Braz J Med Biol Res 44, 871-876.
10. Broadwell RD & Brightman MW (1976). Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood. J Comp Neurol 166, 257-283.
11. Capone C, Faraco G, Peterson JR, Coleman C, Anrather J, Milner TA, Pickel VM, Davisson RL & Iadecola C (2012). Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension. J Neurosci 32, 4878-4886.
12. Cardinale JP, Sriramula S,Mariappan N, Agarwal D & Francis J (2012). Angiotensin II-induced hypertension is modulated by nuclear factor-κB in the paraventricular nucleus. Hypertension 59, 113-121.
13. Casto R & Phillips MI (1984). Mechanism of pressor effects by angiotensin in the nucleus tractus solitarius of rats. Am J Physiol 247, R575-R581.
14. 1 receptors in paraventricular nucleus contribute to sympathetic activation and enhanced cardiac sympathetic afferent reflex in renovascular hypertensive rats. Exp Physiol 96, 94-103.
15. Coble JP, Grobe JL, Johnson AK & Sigmund CD (2015). Mechanisms of brain renin angiotensin system-induced drinking and blood pressure: importance of the subfornical organ. Am J Physiol Regul Integr Comp Physiol 308, R238-R249.
16. Cogan MG (1990). Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 15, 451-458.
17. Dampney RA, Tan PS, Sheriff MJ, Fontes MA & Horiuchi J (2007). Cardiovascular effects of angiotensin II in the rostral ventrolateral medulla: the push-pull hypothesis. Curr Hypertens Rep 9, 222-227.
18. Daneman R (2012). The blood-brain barrier in health and disease. Ann Neurol 72, 648-672.
19. 1R and iNOS in the rostral ventrolateral medulla (RVLM) is essential for the sympathetic hyperactivity and hypertension in the 2K-1CWistar rat model. Am J Hypertens 23, 708-715.
20. Ferguson AV (2009). Angiotensinergic regulation of autonomic and neuroendocrine outputs: critical roles for the subfornical organ and paraventricular nucleus. Neuroendocrinology 89, 370-376.
21. Ferguson AV & Bains JS (1997). Actions of angiotensin in the subfornical organ and area postrema: implications for long term control of autonomic output. Clin Exp Pharmacol Physiol 24, 96-101.
22. Ferrario CM (1983). Neurogenic actions of angiotensin II. Hypertension 5, V73-79.
23. Fink GD (1997). Long-term sympatho-excitatory effect of angiotensin II: a mechanism of spontaneous and renovascular hypertension. Clin Exp Pharmacol Physiol 24, 91-95.
24. 1 receptor in brain endothelial cells. J Cereb Blood Flow Metab 29, 640-647.
25. Fontes MA, Baltatu O, Caligiorne SM, Campagnole-Santos MJ, Ganten D, Bader M & Santos RA (2000). Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats. Physiol Genomics 2, 137-142.
26. Fry M & Ferguson AV (2007). The sensory circumventricular organs: brain targets for circulating signals controlling ingestive behavior. Physiol Behav 91, 413-423.
27. Gabor A & Leenen FH (2012). Central neuromodulatory pathways regulating sympathetic activity in hypertension. J Appl Physiol (1985) 113, 1294-1303.
28. Ganong WF & Murakami K (1987). The role of angiotensin II in the regulation of ACTH secretion. Ann NY Acad Sci 512, 176-186.
29. Ganten D & Speck G (1978). The brain renin-angiotensin system: a model for the synthesis of peptides in the brain. Biochem Pharmacol 27, 2379-2389.
30. Grippo AJ, Kirby RF, Beltz TG & Johnson AK (2002). Angiotensin II-induced drinking and pressor responses to central or systemic irbesartan and losartan. Pharmacol Biochem Behav 71, 139-146.
31. Guyenet PG (2006). The sympathetic control of blood pressure. Nat Rev Neurosci 7, 335-346.
32. Huber DA & Schreihofer AM (2011). Altered regulation of the rostral ventrolateral medulla in hypertensive obese Zucker rats. Am J Physiol Heart Circ Physiol 301, H230-H240.
33. IovinoM & Steardo L (1984). Vasopressin release to central and peripheral angiotensin II in rats with lesions of the subfornical organ. Brain Res 322, 365-368.
34. Ito S, Hiratsuka M, Komatsu K, Tsukamoto K, Kanmatsuse K & Sved AF (2003). Ventrolateral medulla AT1 receptors support arterial pressure in Dahl salt-sensitive rats. Hypertension 41, 744-750.
35. 1 receptors support blood pressure in hypertensive rats. Hypertension 40, 552-559.
36. Jensen LL, Harding JW & Wright JW (1992). Role of paraventricular nucleus in control of blood pressure and drinking in rats. Am J Physiol 262, F1068-F1075.
37. Kang YM, Ma Y, Zheng JP, Elks C, Sriramula S, Yang ZM & Francis J (2009). Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension. Cardiovasc Res 82, 503-512.
38. Lang RE, Rascher W, Heil J, Unger T,Wiedemann G & Ganten D (1981). Angiotensin stimulates oxytocin release. Life Sci 29, 1425-1428.
39. Lazartigues E (2010). Inflammation and neurogenic hypertension: a new role for the circumventricular organs? Circ Res 107, 166-167.
40. Leenen FH (2014). Actions of circulating angiotensin II and aldosterone in the brain contributing to hypertension. Am J Hypertens 27, 1024-1032.
41. Lenkei Z, Palkovits M, Corvol P & Llorens-Cortes C (1997). Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol 18, 383-439.
42. Li HB, Qin DN, Ma L, Miao YW, Zhang DM, Lu Y, Song XA, Zhu GQ & Kang YM (2014). Chronic infusion of lisinopril into hypothalamic paraventricular nucleus modulates cytokines and attenuates oxidative stress in rostral ventrolateral medulla in hypertension. Toxicol Appl Pharmacol 279, 141-149.
43. Li W, Peng H, Seth DM & Feng Y (2012). The prorenin and (pro)renin receptor: new players in the brain renin-angiotensin system? Int J Hypertens 2012, 290635.
44. Li Z & Ferguson AV (1993). Subfornical organ efferents to paraventricular nucleus utilize angiotensin as a neurotransmitter. Am J Physiol 265, R302-R309.
45. MacGregor DP, Murone C, Song K, Allen AM, Paxinos G & Mendelsohn FA (1995). Angiotensin II receptor subtypes in the human central nervous system. Brain Res 675, 231-240.
46. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FA & Chai SY (2003). The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 35, 901-918.
47. McKinley MJ, Allen AM, Mathai ML, May C, McAllen RM, Oldfield BJ & Weisinger RS (2001). Brain angiotensin and body fluid homeostasis. Jpn J Physiol 51, 281-289.
48. 2 receptors in the brain. Clin Exp Pharmacol Physiol 23, Suppl. 3, S99-104.
49. Mancia G, Grassi G, Giannattasio C & Seravalle G (1999). Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 34, 724-728.
50. Marvar PJ, Lob H, Vinh A, Zarreen F & Harrison DG (2011). The central nervous system and inflammation in hypertension. Curr Opin Pharmacol 11, 156-161.
51. Marvar PJ, Thabet SR, Guzik TJ, Lob HE,McCann LA,Weyand C, Gordon FJ & Harrison DG (2010). Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 107, 263-270.
52. MayhanWG, Faraci FM, Siems JL & Heistad DD (1989). Role of molecular charge in disruption of the blood-brain barrier during acute hypertension. Circ Res 64, 658-664.
53. Mendelsohn FA, Quirion R, Saavedra JM, Aguilera G & Catt KJ (1984). Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci USA 81, 1575-1579.
54. Miyoshi M, Miyano K, Moriyama N, Taniguchi M & Watanabe T (2008). Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor ? B and activator protein-1 activation. Eur J Neurosci 27, 343-351.
55. Muratani H, Averill DB & Ferrario CM (1991). Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats. Am J Physiol 260, R977-R984.
56. Nishi EE, Bergamaschi CT, Oliveira-Sales EB, Simon KA & Campos RR (2013). Losartan reduces oxidative stress within the rostral ventrolateral medulla of rats with renovascular hypertension. Am J Hypertens 26, 858-865.
57. Obermeier B, Daneman R & Ransohoff RM (2013). Development, maintenance and disruption of the blood-brain barrier. Nat Med 19, 1584-1596.
58. Oliveira-Sales EB, Nishi EE, Carillo BA, Boim MA, Dolnikoff MS, Bergamaschi CT & Campos RR (2009). Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am J Hypertens 22, 484-492.
59. Osborn JW, Fink GD, Sved AF, Toney GM & Raizada MK (2007). Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 9, 228-235.
60. Parati G & Esler M (2012). The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J 33, 1058-1066.
61. Paton JF, Deuchars J, Ahmad Z,Wong LF, Murphy D & Kasparov S (2001). Adenoviral vector demonstrates that angiotensin II-induced depression of the cardiac baroreflex is mediated by endothelial nitric oxide synthase in the nucleus tractus solitarii of the rat. J Physiol 531, 445-458.
62. Paton JF & Waki H (2009). Is neurogenic hypertension related to vascular inflammation of the brainstem? Neurosci Biobehav Rev 33, 89-94.
63. Paton JF,Wang S, Polson JW & Kasparov S (2008). Signalling across the blood brain barrier by angiotensin II: novel implications for neurogenic hypertension. J MolMed (Berl) 86, 705-710.
64. Pelisch N, Hosomi N, Mori H, Masaki T & Nishiyama A (2013). RAS inhibition attenuates cognitive impairment by reducing blood- brain barrier permeability in hypertensive subjects. Curr Hypertens Rev 9, 93-98.
65. Pelisch N, Hosomi N, UenoM, Nakano D, Hitomi H, Mogi M, Shimada K, Kobori H, Horiuchi M, Sakamoto H, Matsumoto M, Kohno M & Nishiyama A (2011). Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats. Am J Hypertens 24, 362-368.
66. Perret-Guillaume C, Joly L, Jankowski P & Benetos A (2009). Benefits of the RAS blockade: clinical evidence before the ONTARGET study. J Hypertens Suppl 27, S3-7.
67. Pires PW, Dams Ramos CM, Matin N & Dorrance AM (2013). The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol 304, H1598-H1614.
68. Qi J, Zhang DM, Suo YP, Song XA, Yu XJ, Elks C, Lin YX, Xu YY, Zang WJ, Zhu Z & Kang YM (2013). Renin-angiotensin system modulates neurotransmitters in the paraventricular nucleus and contributes to angiotensin II-induced hypertensive response. Cardiovasc Toxicol 13, 48-54.
69. Rodriguez-Pallares J, Rey P, Parga JA, Munoz A, Guerra MJ & Labandeira-Garcia JL (2008). Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. Neurobiol Dis 31, 58-73.
70. Saijo K & Glass CK (2011). Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11, 775-787.
71. Sanderford MG & Bishop VS (2002). Central mechanisms of acute ANG II modulation of arterial baroreflex control of renal sympathetic nerve activity. Am J Physiol Heart Circ Physiol 282, H1592-H1602.
72. Shaver SW,Wall KM,Wainman DS & Gross PM (1992). Regional quantitative permeability of blood-brain barrier lesions in rats with chronic renal hypertension. Brain Res 579, 99-106.
73. Shi P, Diez-Freire C, Jun JY, Qi Y, KatovichMJ, Li Q, Sriramula S, Francis J, Sumners C & Raizada MK (2010). Brain microglial cytokines in neurogenic hypertension. Hypertension 56, 297-303.
74. Song K, Allen AM, Paxinos G & Mendelsohn FA (1992). Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J Comp Neurol 316, 467-484.
75. Sriramula S, Cardinale JP & Francis J (2013). Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension. PLoS One 8, e63847.
76. Stamatovic SM, Keep RF & Andjelkovic AV (2008). Brain endothelial cell-cell junctions: how to 'open' the blood brain barrier. Curr Neuropharmacol 6, 179-192.
77. Sun H, Miller DW & Elmquist WF (2001). Effect of probenecid on fluorescein transport in the central nervous system using in vitro and in vivo models. Pharm Res 18, 1542-1549.
78. Swanson LW & Sawchenko PE (1983). Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Ann Rev Neurosci 6, 269-324.
79. 1 receptors in the nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol 293, R2267-R2278.
80. Toney GM & Porter JP (1993a). Effects of blockade of AT1 and AT2 receptors in brain on the central angiotensin II pressor response in conscious spontaneously hypertensive rats. Neuropharmacology 32, 581-589.
81. Toney GM & Porter JP (1993b). Functional role of brain AT1 and AT2 receptors in the central angiotensin II pressor response. Brain Res 603, 57-63.
82. Ueno M, Sakamoto H, Liao YJ, Onodera M, Huang CL, Miyanaka H & Nakagawa T (2004). Blood-brain barrier disruption in the hypothalamus of young adult spontaneously hypertensive rats. Histochem Cell Biol 122, 131-137.
83. Villapol S & Saavedra JM (2015). Neuroprotective effects of angiotensin receptor blockers. Am J Hypertens 28, 289-299.
84. Vital SA, Terao S, Nagai M & Granger DN (2010). Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension. Microcirculation 17, 641-649.
85. Waki H, Gouraud SS, Maeda M, Raizada MK & Paton JF (2011). Contributions of vascular inflammation in the brainstem for neurogenic hypertension. Respir Physiol Neurobiol 178, 422-428.
86. Waki H, Liu B,MiyakeM, Katahira K,Murphy D, Kasparov S & Paton JF (2007). Junctional adhesion molecule-1 is upregulated in spontaneously hypertensive rats: evidence for a prohypertensive role within the brain stem. Hypertension 49, 1321-1327.
87. Waubant E (2006). Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis. Dis Markers 22, 235-244.
88. Winklewski PJ, Radkowski M, Wszedybyl-Winklewska M & Demkow U (2015). Brain inflammation and hypertension: the chicken or the egg? J Neuroinflammation 12, 85.
89. Wong AD, Ye M, Levy AF, Rothstein JD, Bergles DE & Searson PC (2013). The blood-brain barrier: an engineering perspective. Front Neuroeng 6, 7.
90. Yang Y & Rosenberg GA (2011). Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42, 3323-3328.
91. Yao ST & May CN (2013). Intra-carotid angiotensin II activates tyrosine hydroxylase-expressing rostral ventrolateral medulla neurons following blood-brain barrier disruption in rats. Neuroscience 245, 148-156.
92. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR & Davisson RL (2002). Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91, 1038-1045.
93. Zimmerman MC, Lazartigues E, Sharma RV & Davisson RL (2004). Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95, 210-216.